Vigigan en es it fr

Vigigan Brand names, Vigigan Analogs

Vigigan Brand Names Mixture

  • No information avaliable

Vigigan Chemical_Formula


Vigigan RX_link

No information avaliable

Vigigan fda sheet

Vigigan msds (material safety sheet)

Vigigan Synthesis Reference

G. Gueremy et al., Ger. pat. 2,009,555 corresp to U.S. pat. 3,987,042 (1970, 1976 to Sogeras)

Vigigan Molecular Weight

322.468 g/mol

Vigigan Melting Point

130.5 oC

Vigigan H2O Solubility

No information avaliable

Vigigan State


Vigigan LogP


Vigigan Dosage Forms


Vigigan Indication

For the treatment of Hay fever, urticaria (hives) and allergic rhinitis

Vigigan Pharmacology

In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Mequitazine is a histamine H1 antagonist. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.

Vigigan Absorption

No information avaliable

Vigigan side effects and Toxicity

No information avaliable

Vigigan Patient Information

No information avaliable

Vigigan Organisms Affected

Humans and other mammals